Key topics of discussion will include:
BACE1 inhibitors and/or γ-secretase modulators for reducing amyloid deposition
Active and passive vaccination for enhancing clearance of amyloid plaques
Vaccines for reducing tau pathology
Antisense approaches for AD, PD and ALS therapy
Neural stem cell approaches for neurodegeneration
Inflammatory modulators for neurodegeneration.
Genetic linkage study and big data approaches
Novel therapeutic targets
The significance of having this conference is to provide a unique forum for the research community focusing on translational studies geared towards therapies in AD and related neurodegenerative diseases to come together to discuss the latest advances and the future challenges in the field.